Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
-
Selumetinib granted orphan designation in Europe for neurofibromatosis type 1
-
Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung cancer
-
H1 2018 Results
-
Atacand to be divested to Cheplapharm in Europe
-
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
-
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
-
Bydureon receives positive EU CHMP opinion for new BCise device for patients with type-2 diabetes
-
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
-
AstraZeneca to share latest data from an industry-leading portfolio that aims to advance clinical understanding of diabetes and CV risk management at ADA 2018
Latest articles and press releases
All of our latest press releases and articles are available to explore
